Scarica l'app Stockscreener
22.23
1.20%
-0.27
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ROIV Giù?
Forum
Previsione
Roivant Sciences Ltd Borsa (ROIV) Ultime notizie
Capricorn Fund Managers Ltd Buys New Stake in Roivant Sciences Ltd. $ROIV - MarketBeat
Insider Confidence In December 2025's Leading Growth Companies - Yahoo! Finance Canada
Reassessing Roivant Sciences (ROIV) Valuation After Pipeline Progress, NDA Timelines and Genevant Litigation Updates - simplywall.st
Voya Investment Management LLC Grows Stock Position in Roivant Sciences Ltd. $ROIV - MarketBeat
Is Roivant Sciences Ltd stock positioned for digital transformationGap Down & High Conviction Trade Alerts - moha.gov.vn
What margin trends mean for Roivant Sciences Ltd. stockFibonacci Extensions & Fast Profit Trading Tips - bollywoodhelpline.com
Ramaswamy-Backed Ambros Launches with $125M - Orange County Business Journal
Roivant Sciences president Sukhatme sells $619k in shares By Investing.com - Investing.com Australia
Roivant Sciences president Sukhatme sells $619k in shares - Investing.com UK
How Investors May Respond To Roivant Sciences (ROIV) Accelerating Brepocitinib Timelines And Patent Litigation - simplywall.st
H.C. Wainwright Keeps Buy Rating on Roivant Sciences (ROIV) Stock - MSN
Why Roivant Sciences Ltd. stock is in analyst buy zone2025 Fundamental Recap & Reliable Entry Point Trade Alerts - Улправда
US Market Recap: What margin trends mean for Roivant Sciences Ltd stockJuly 2025 Fed Impact & Weekly High Conviction Trade Ideas - moha.gov.vn
Sell Signal: Will Roivant Sciences Ltd stock maintain momentum in 2025Weekly Stock Report & Pattern Based Trade Signal System - moha.gov.vn
Why Roivant Sciences Ltd. stock could be next big winner2025 Trading Recap & Stepwise Trade Signal Implementation - ulpravda.ru
Can Roivant Sciences Ltd. stock maintain operating marginsJuly 2025 Chart Watch & Accurate Buy Signal Notifications - Улправда
How Roivant Sciences Ltd. (87S) stock reacts to fiscal policiesJuly 2025 EndofMonth & Free Expert Verified Stock Movement Alerts - Улправда
Roivant Sciences (NASDAQ:ROIV) Insider Mayukh Sukhatme Sells 26,831 Shares - MarketBeat
Pres Sukhatme Sells 26,831 ($619.5K) Of Roivant Sciences Ltd [ROIV] - TradingView — Track All Markets
Can Roivant Sciences Ltd. stock double in next 5 yearsWeekly Market Summary & Daily Technical Stock Forecast Reports - ulpravda.ru
Can Roivant Sciences Ltd. stock outperform in 2025 bull marketMarket Activity Summary & High Conviction Buy Zone Alerts - DonanımHaber
Why Roivant Sciences Ltd. stock remains undervaluedVolume Spike & Consistent Return Strategy Ideas - Bölüm Sonu Canavarı
Will Roivant Sciences Ltd. stock maintain momentum in 2025Weekly Stock Analysis & Long-Term Growth Plans - DonanımHaber
Roivant Sciences Insider Sold Shares Worth $39,065,213, According to a Recent SEC Filing - marketscreener.com
Published on: 2025-12-19 09:31:09 - ulpravda.ru
Will Roivant Sciences Ltd. stock deliver shareholder valueQuarterly Trade Report & Long-Term Safe Return Strategies - Улправда
Roivant Sciences (NASDAQ:ROIV) Director Daniel Allen Gold Sells 777,332 Shares - MarketBeat
Insider Selling: Roivant Sciences (NASDAQ:ROIV) Director Sells 917,282 Shares of Stock - MarketBeat
Roivant Sciences (ROIV) director discloses indirect sales of common shares - Stock Titan
Owner QVT Financial LP Sells 1,694,614 ($39.1M) Of Roivant Sciences Ltd [ROIV] - TradingView — Track All Markets
Why Roivant Sciences Ltd. stock remains resilientJuly 2025 Drop Watch & Free Real-Time Market Sentiment Alerts - ulpravda.ru
Why analysts remain bullish on Roivant Sciences Ltd. stock2025 Analyst Calls & Accurate Entry and Exit Point Alerts - Улправда
Is Immunovant Stock a Buy After Roivant Sciences Increased Its Stake by $350 Million? - AOL.com
Published on: 2025-12-18 16:03:55 - Улправда
Roivant Sciences Insider Sold Shares Worth $37,723,200, According to a Recent SEC Filing - marketscreener.com
Is Immunovant Stock a Buy After Roivant Sciences Increased Its Stake by $350 Million? - The Motley Fool
Insider Selling: Roivant Sciences (NASDAQ:ROIV) CEO Sells 1,740,000 Shares of Stock - MarketBeat
Pres Sukhatme Files To Sell 26,831 Of Roivant Sciences Ltd [ROIV] - TradingView — Track All Markets
Valeo Financial Advisors LLC Purchases New Position in Roivant Sciences Ltd. $ROIV - MarketBeat
Roivant Sciences (NASDAQ:ROIV) Sets New 12-Month HighShould You Buy? - MarketBeat
Roivant Sciences (ROIV): Reassessing Valuation After Bullish Pipeline and Patent Milestone Updates - simplywall.st
Leerink Partners Maintains Roivant Sciences (ROIV) Outperform Recommendation - Nasdaq
Roivant Sciences stock hits all-time high at 22.45 USD By Investing.com - Investing.com Australia
Insider Selling: Roivant Sciences (NASDAQ:ROIV) Major Shareholder Sells $16,752,432.88 in Stock - MarketBeat
Roivant Sciences (ROIV): Ramaswamy Vivek sells $67.9 million in shares By Investing.com - Investing.com South Africa
Roivant Sciences (ROIV): Ramaswamy Vivek sells $67.9 million in shares - Investing.com
Owner Ramaswamy Sells 3,103,745 ($67.9M) Of Roivant Sciences Ltd [ROIV] - TradingView — Track All Markets
CEO Gline Files To Sell 1,740,000 Of Roivant Sciences Ltd [ROIV] - TradingView — Track All Markets
Immunovant (IMVT) Is Up 14.0% After Roivant-Backed $550 Million Equity Raise For IMVT-1402Has The Bull Case Changed? - Yahoo! Finance Canada
Roivant Sciences (NASDAQ:ROIV) Given New $33.00 Price Target at The Goldman Sachs Group - MarketBeat
Roivant Sciences stock price target raised to $26 from $23 at H.C. Wainwright - Investing.com Australia
0.08%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):